UPDATE 1-Allergan forecasts 2nd-half revenue above $8 bln
September 28, 2015 at 17:39 PM EDT
Sept 28 (Reuters) - Drugmaker Allergan Plc said it expected revenue to be greater than $8 billion in the second half as it completes the sale of its generics business to Teva Pharmaceuticals Industries Ltd .
